Liquid biopsy is increasingly recognized as a promising tool for cancer detection and treatment monitoring, yet its ...

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today shared the results from two oral ...

Researchers have discovered that analyzing specific patterns of cell-free DNA (cfDNA) fragmentation in a simple urine sample ...

Younger donor age (18-35) is crucial for stem cell transplant success and patient survival; superseding related sibling matches and older donor paradigms.

Liquid biopsy is increasingly recognized as a promising tool for cancer detection and treatment monitoring, yet its ...

Seq, a CRISPR-based method that enriches ultra-rare tumor DNA in blood by removing background wild-type DNA before sequencing ...

MUTE-Seq is a new liquid-biopsy method powered by an engineered ultra-precise CRISPR enzyme, FnCas9-AF2, which can ...

GC Genome, a leading clinical genomics and liquid biopsy company, announced that its study analyzing cell-free DNA (cfDNA) ...

One therapy wey pipo bin once reason as achievement for science fiction don reverse aggressive and incurable blood cancers ...

Liquid biopsy is increasingly recognized as a promising tool for cancer detection and treatment monitoring, yet its effectiveness is often limited by ...

A groundbreaking gene therapy, BE-CAR7, has shown remarkable success in reversing an aggressive form of leukemia. This ...

A seventh person has been ‘cured’ of the HIV through a stem cell transplant. But the treatment can only be used for people with fatal cancers as it is very risky to be attempted in people without ...